Wearable Injector Market Witnesses Upward Trend with High Prevalence of Diabetes | Medtronic Plc, West Pharmaceutical Services, Inc., Enable Injections, F. Hoffmann-La Roche Ltd

Wearable Injector devices are used in many clinical settings, such as: infectious disease clinics, medical centers, chronic care facilities, pharmacies, clinics, and physicians’ offices. These devices allow for a quick and reliable delivery of sterile therapeutic doses. As medical studies continue to progress and identify new uses for injectable drug products, the ability to deliver customized and precise doses with minimal exposure to symptoms or environmental risks will become even more important. The release of these devices will enable easy administration of high doses of medicines and other pharmaceutical products in a safe and efficient manner.

Get FREE Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/970

Wearable Injector Market Taxonomy:

By Product type

• On-body (Adhesive patch)
• Off-body (Belt clip)
• Hand-Held

By Usage

• Disposable
• Semi-Reusable

By Technology

• Spring-based
• Motor-driven
• Rotary Pump
• Expanding battery
• Pressurized Gas
• Collapsible Reservoir

By Application

• Cardiovascular
• Autoimmune diseases
• Diabetes
• Oncology
• Infectious Diseases
• Others

By End-use Industry

• Hospital
• Clinics
• Home-care
• Ambulatory Service

Advent of new wearable injectors to improve drug delivery system is expected to propel the growth of wearable injector market

In 2015, Unilife Corporation introduced Imperium, which is an instant patch pump used for insulin. Imperium is a subcutaneous insulin infusion, disposable, prefilled, and multi-day wearable insulin pump. It has various features that include data connectivity for app to constantly remind and update wireless connectivity such as Bluetooth LE. It also provide real-time access to healthcare provider to track the insulin therapy of each patient.

In 2014, Enable Injections LLC has signed an agreement with CSL Behring to develop novel drug delivery devices. Enable Injectors intent to improve comfort, convenience, and compliance administrative device for the patients with rare diseases.

𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!!!!!!!

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏

Purchase This Premium Report With Discounted Rate @ https://www.coherentmarketinsights.com/insight/buy-now/970

Enable Injection LLC and Flex entered in partnership to develop and manufacture wearable medical device in 2016. Enable and Flex aims to develop subcutaneous pain-free injection technology with features such as Bluetooth connectivity, monitoring system with smartphone app, mix automation, and passive warming system.

Unilife Corporation entered in an agreement with Amgen to develop customized wearable injectors in 2016. Unilife has granted exclusive rights to Amgen for Unilife’s wearable injectors, with only selected drug classes are used for wearable injector device. Furthermore, Unilife also granted some non-exclusive rights to Amgen for its delivery system of certain therapeutic area that include inflammation, nephrology, oncology, bone health, neuroscience, and cardiovascular.

Growing prevalence of chronic diseases and rising demand for advanced drug delivery device for frequent administration of drug is augmenting the market growth

According to the World Health Organization (WHO), around 1.6 million deaths caused by diabetes in 2015 and is expected to increase by more than 50% before the age of 70 years by 2030. Moreover, According to National Institute of Health (NIH), in 2017, around 23.5 million people are suffering from autoimmune diseases in U.S.

According to World Health Organization (WHO), in 2017, nearly 1 in every 6 death occurs due to cancer globally and approximately 70% of deaths from cancer occur in low and middle-income countries. Growing prevalence of chronic disease and high demand for efficient and advanced drug delivery devices for frequent drug administration is expected to foster the growth of wearable injector market over the forecast period.

key players operating in the global wearable injector market include Medtronic Plc, West Pharmaceutical Services, Inc., Enable Injections, F. Hoffmann-La Roche Ltd, scPharmaceuticals, Inc, Johnson & Johnson, Insulet Corporation, Sensile Medical Ag, Becton, and Dickinson And Company.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/970

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Wearable Injector Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Wearable Injector Industry Impact

Chapter 2 Global Wearable Injector Competition by Types, Applications, and Top Regions and Countries
2.1 Global Wearable Injector (Volume and Value) by Type
2.3 Global Wearable Injector (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Wearable Injector Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Wearable Injector Market Analysis
Chapter 6 East Asia Wearable Injector Market Analysis
Chapter 7 Europe Wearable Injector Market Analysis
Chapter 8 South Asia Wearable Injector Market Analysis
Chapter 9 Southeast Asia Wearable Injector Market Analysis
Chapter 10 Middle East Wearable Injector Market Analysis
Chapter 11 Africa Wearable Injector Market Analysis
Chapter 12 Oceania Wearable Injector Market Analysis
Chapter 13 South America Wearable Injector Market Analysis
Chapter 14 Company Profiles and Key Figures in Wearable Injector Business
Chapter 15 Global Wearable Injector Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology

Do You Have Specific Requirement? Ask To Our Experts: https://www.coherentmarketinsights.com/insight/talk-to-analyst/970